L'équipe du département de pharmacologie

FIELDS

CONTACT

 

 

 

Université Bordeaux 2 CHU de Bordeaux INSERM
Département Hospitalo-Universitaire de Pharmacologie de Bordeaux
fren
  • Home
  • Publications in 2020

PUBLICATIONS in 2020

Publications' last update : 2021-02-22

  1. Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade >=2 immune-related adverse events in patients with cancer
    J Immunother Cancer. 2020 (8-2) e001622
    Allouchery M, Lombard T, Martin M, Rouby F, Sassier M, Bertin C, Atzenhoffer M, Miremont-Salame G, Perault-Pochat MC, Puyade M; French Network of Regional Pharmacovigilance Centers.
     PubMed citation

  2. Patterns of use and safety of ibrutinib in real-life practice
    Br J Clin Pharmacol. 2020 (ahead of print)
    Allouchery M, Tomowiak C, Guidez S, Delwail V, Delaunay P, Lafay-Chebassier C, Salvo F, Pérault-Pochat MC.
     PubMed citation

  3. Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)
    Drug Saf. 2020 (ahead of print)
    Arlegui H, Bollaerts K, Bauchau V, Nachbaur G, Bégaud B, Praet N.
     PubMed citation

  4. Benefit-Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit-Risk Models Applied to Vaccines
    Drug Saf. 2020 (ahead of print)
    Arlegui H, Bollaerts K, Salvo F, Bauchau V, Nachbaur G, Bégaud B, Praet N.
     PubMed citation

  5. Quantitative Benefit-Risk Models Used for Rotavirus Vaccination: A Systematic Review
    Open Forum Infect Dis. 2020 (7-4) ofaa087
    Arlegui H, Nachbaur G, Praet N, Bégaud B.
     PubMed citation

  6. Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit-Risk Models: The Example of Rotavirus Vaccination in France
    Clin Ther. 2020 (ahead of print)
    Arlegui H, Nachbaur G, Praet N, Bégaud B, Caro JJ.
     PubMed citation

  7. Augmentation des complications sanitaires graves lors de l’usage non-médical du protoxyde d’azote en France
    Therapie. 2020 (ahead of print)
    Association française des centres d’addictovigilance, Micallef J, Mallaret M, Lapeyre-Mestre M, Daveluy A, Victorri-Vigneau C, Peyrière H, Debruyne D, Deheul S, Bordet R, Chevallier C, Perault-Pochat MC, Le Boisselier R, Libert F, Chaouachi L, Gillet P.
     PubMed citation

  8. Impact of pregnancy on antidepressant treatment course: a population-based comparative cohort study in France
    Arch Womens Ment Health. 2020 (ahead of print)
    Bénard-Laribière A, Pambrun E, Sutter-Dallay AL, Gautier S, Hurault-Delarue C, Damase-Michel C, Lacroix I, Pariente A.
     PubMed citation

  9. Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database
    Drug Saf. 2020 (ahead of print)
    Berbain T, Pariente A, Miremont-Salamé G, Grandvuillemin A, Micallef J, Chouchana L, Benkebil M, Théophile H; French Network of Pharmacovigilance Centres.
     PubMed citation

  10. Antidopaminergic antiemetics and trauma-related hospitalization: a population-based self-controlled case series study
    Br J Clin Pharmacol. 2020 (ahead of print)
    Bezin J, Noize P, Mansiaux Y, Jarne A, Pariente A.
     PubMed citation

  11. Secondary prevention of acute coronary syndrome with antiplatelet agents in real life: A high-dimensional propensity score matched cohort study in the French National claims database
    MethodsX. 2020 (7) 100796
    Blin P, Dureau-Pournin C, Jové J, Lassalle R, Droz C, Moore N.
     PubMed citation

  12. Patterns of quadruple therapy use including bismuth for Helicobacter pylori eradication: A cohort study in the French national claims database
    Therapie. 2020 (ahead of print)
    Blin P, Rouyer M, Guiard E, Zerbib F, Diquet B, Mégraud F, Tison F, Abouelfath A, Lassalle R, Droz-Perroteau C, Moore N.
     PubMed citation

  13. Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial
    Trials. 2020 (21-1) 342
    Bonnet F, Bénard A, Poulizac P, Afonso M, Maillard A, Salvo F, Berdaï D, Salles N, Rousselot N, Marchi S, Hayes N, Joseph JP.
     PubMed citation

  14. Treatment resistant depression incidence and prevalence using the French nationwide claims database
    Pharmacoepidemiol Drug Saf. 2020 (ahead of print)
    Bosco-Lévy P, Grelaud A, Blin P, Astruc B, Falissard B, Llorca PM, Bernard MA, Lassalle R, Moore N, Droz-Perroteau C.
     PubMed citation

  15. Population pharmacokinetics of ceftazidime in critically ill children: impact of cystic fibrosis
    J Antimicrob Chemother. 2020 (ahead of print)
    Bui S, Facchin A, Ha P, Bouchet S, Leroux S, Nacka F, Fayon M, Jacqz-Aigrain E; network of Paediatric Clinical Investigation Centres.
     PubMed citation

  16. Are standard dosing regimens of Amikacin suitable in Critically Ill Patients with Open Abdomen and Negative Pressure Wound Therapy? A population pharmacokinetic study
    Antimicrob Agents Chemother. 2020 (ahead of print)
    Carrié C, Delzor F, Roure S, Dubuisson V, Petit L, Molimard M, Breilh D, Biais M.
     PubMed citation

  17. Overview of French databases available for studying anticancer drugs in real life setting
    Fundam Clin Pharmacol. 2020 (ahead of print)
    Casarotto E, Noize P, Gouverneur A, Berdaï D, Bégaud B, Levy-Bachelot L, Molimard M.
     PubMed citation

  18. Safety Profile of Drugs for Advanced Melanoma: A Report Based on 2008 to 2018 United States Food and Drug Administration Data
    Br J Clin Pharmacol. 2020 (ahead of print)
    Casarotto E, Noize P, Létinier L, Salvo F, Pham-Ledard A, Molimard M.
     PubMed citation

  19. Dolutegravir and neural tube defects: a new insight
    Lancet Infect Dis. 2020 (20-4) 405-406
    Chouchana L, Pariente A, Pannier E, Tsatsaris V, Treluyer JM.
     PubMed citation

  20. Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)
    Cancers (Basel). 2020 (12-4) pii: E826
    Cirmi S, El Abd A, Letinier L, Navarra M, Salvo F.
     PubMed citation

  21. Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemic
    Therapie. 2020 (ahead of print)
    Cracowski JL, Molimard M, Richard V.
     PubMed citation

  22. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis
    Orphanet J Rare Dis. 2020 (15-1) 141
    Crisafulli S, Sultana J, Fontana A, Salvo F, Messina S, Trifirò G.
     PubMed citation

  23. Ten-year trend of opioid and non-opioid analgesic use in the French adult population
    Br J Clin Pharmacol. 2020 (87-2) 555-564
    Daveluy A, Micallef J, Sanchez-Pena P, Miremont-Salamé G, Lassalle R, Lacueille C, Grelaud A, Corand V, Victorri-Vigneau C, Batisse A, Le Boisselier R, Peyrière H, Frauger E, Lapeyre-Mestre M, Haramburu F; French Addictovigilance Network.
     PubMed citation

  24. [Use of synthetic substances in France and in Europe]
    Therapie. 2020 (ahead of print)
    Debruyne D, Monzon E, Perino J, Haramburu F, Daveluy A, Lazès-Charmetant A, Giraudon I.
     PubMed citation

  25. Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score Strategies
    Drug Saf. 2020 (ahead of print)
    Demailly R, Escolano S, Haramburu F, Tubert-Bitter P, Ahmed I.
     PubMed citation

  26. The effect of the Music Day event on community drug use
    Forensic Sci Int. 2020 (ahead of print)
    Devault DA, Peyré A, Jaupitre O, Daveluy A, Karolak S.
     PubMed citation

  27. Reprint of: The effect of the Music Day event on community drug use
    Forensic Sci Int. 2020 (ahead of print)
    Devault DA, Peyré A, Jaupitre O, Daveluy A, Karolak S.
     PubMed citation

  28. Allergen immunotherapy: what is the added value of real-world evidence from retrospective claims database studies?
    Expert Rev Respir Med. 2020 (ahead of print)
    Devillier P, Demoly P, Molimard M.
     PubMed citation

  29. Primary Care of Opioid use Disorder: The End of "the French Model"?
    Eur Addict Res. 2020 (ahead of print)
    Dupouy J, Maumus-Robert S, Mansiaux Y, Pariente A, Lapeyre-Mestre M.
     PubMed citation

  30. Health consequences of cocaine use in France: data from the French addictovigilance network
    Fundam Clin Pharmacol. 2020 (ahead of print)
    Eiden C, Vincent M, Serrand C, Serre A, Richard N, Picot MC, Frauger E, Fouilhé N, Daveluy A, Peyrière H; French Addictovigilance Network (FAN).
     PubMed citation

  31. Factors associated with serious vehicular accidents: a cross-sectional study in hospital emergency rooms
    Br J Clin Pharmacol. 2020 (87-2) 612-621
    Forest K, Valdenaire G, Lorendeau JP, Sagaspe P, Contrand B, Durand-Teyssier C, Sakr D, Gil-Jardine C, Boutreux S, Lagarde E, Peyrouzet H, Lassalle R, Moore N, Philip P, Girodet PO.
     PubMed citation

  32. Warning on increased serious health complications related to non-medical use of nitrous oxide
    Therapie. 2020 (ahead of print)
    French Association of Addictovigilance Centres, Micallef J, Mallaret M, Lapeyre-Mestre M, Daveluy A, Victorri-Vigneau C, Peyrière H, Debruyne D, Deheul S, Bordet R, Chevallier C, Perault-Pochat MC, Le Boisselier R, Libert F, Chaouachi L, Gillet P.
     PubMed citation

  33. The 2019 Global Initiative for Asthma report: Evidence-based or evidence-biased medicine?
    Therapie. 2020 (ahead of print)
    Girodet PO, Molimard M.
     PubMed citation

  34. Suitability of infrared spectroscopy for drug checking in harm reduction centres
    Int J Drug Policy. 2020 (ahead of print)
    Goncalves R, Titier K, Latour V, Peyré A, Castaing N, Daveluy A, Molimard M.
     PubMed citation

  35. Agomelatine in Standard Medical Practice in Depressed Patients: Results of a 1-Year Multicentre Observational Study In France
    Clin Drug Investig. 2020 (ahead of print)
    Gorwood P, Benichou J, Moore N, Wattez M, Secouard MC, Desobry X, Picarel-Blanchot F, de Bodinat C.
     PubMed citation

  36. DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting database
    Lancet Diabetes Endocrinol. 2020 (8-5) 365-367
    Gouverneur A, Lair A, Arnaud M, Bégaud B, Raschi E, Pariente A, Salvo F.
     PubMed citation

  37. The Burden of Potentially Inappropriate Medications in Chronic Polypharmacy
    J Clin Med. 2020 (9-11) 3728
    Guillot J, Maumus-Robert S, Marceron A, Noize P, Pariente A, Bezin J.
     PubMed citation

  38. [Research ethics: French regulations and applications in radiation oncology]
    Cancer Radiother. 2020 (24-4) 306-315
    Haaser T, Berdaï D, Trouette R, Dupin C, Marty S, L'Azou B, Berger V, Saux MC.
     PubMed citation

  39. Impact of benzodiazepine consumption reduction on future burden of dementia
    Sci Rep. 2020 (10-1) 14666
    Jacqmin-Gadda H, Guillet F, Mathieu C, Helmer C, Pariente A, Joly P.
     PubMed citation

  40. Quality of Life and Pain During Treatment of Metastatic Castration-resistant Prostate Cancer With Cabazitaxel In Routine Clinical Practice
    Clin Genitourin Cancer. 2020 (ahead of print)
    Joly F, Oudard S, Fizazi K, Tubach F, Jove J, Lacueille C, Lamarque S, Guiard E, Balestra A, Droz-Perroteau C, Fourrier-Reglat A, Rouyer M, Moore N.
     PubMed citation

  41. COVID-19 infection also occurs in patients taking hydroxychloroquine
    J Antimicrob Chemother. 2020 (75-7) 2014-2015
    Lahouati M, Mériglier E, Martin L, Bouchet S, Desclaux A, Bonnet F.
     PubMed citation

  42. Addictovigilance contribution during COVID-19 epidemic and lockdown in France
    Therapie. 2020 (75-4) 343-354
    Lapeyre-Mestre M, Boucher A, Daveluy A, Gibaja V, Jouanjus E, Mallaret M, Peyrière H, Micallef J; French Addictovigilance Network.
     PubMed citation

  43. [Substance use among young people: From medicine to illicit substances]
    Therapie. 2020 (ahead of print)
    Lapeyre-Mestre M, Boyer A, Ponté C, Daveluy A, Godeau E.
     PubMed citation

  44. Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic
    Fundam Clin Pharmacol. 2020 (34-3) 389-396
    Larrouquere L, Gabin M, Poingt E, Mouffak A, Hlavaty A, Lepelley M, Khouri C, Bellier A, Alexandre J, Bedouch P, Bertoletti L, Bordet R, Bouhanick B, Jonville-Bera AP, Laporte S, Le Jeunne C, Letinier L, Micallef J, Naudet F, Roustit M, Molimard M, Richard V, Cracowski JL; Société Française de Pharmacologie et de Thérapeutique, Hôpital Bretonneau, Tours, France.
     PubMed citation

  45. Association between anxiolytic/hypnotic drugs and suicidal thoughts or behaviors in a population-based cohort of students
    Psychiatry Res. 2020 (ahead of print)
    Lecat N, Fourrier-Réglat A, Montagni I, Tzourio C, Pariente A, Verdoux H, Tournier M.
     PubMed citation

  46. Patterns of Benzodiazepine Use and Excess Risk of All-Cause Mortality in the Elderly: A Nationwide Cohort Study
    Drug Saf. 2020 (ahead of print)
    Mathieu C, Joly P, Jacqmin-Gadda H, Wanneveich M, Bégaud B, Pariente A.
     PubMed citation

  47. Risk of Intracranial Aneurysm and Dissection and Fluoroquinolone Use: A Case-Time-Control Study
    Stroke. 2020 (51-3) 994-997
    Maumus-Robert S, Debette S, Bérard X, Mansiaux Y, Tubert-Bitter P, Pariente A.
     PubMed citation

  48. Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection
    J Antimicrob Chemother. 2020 (ahead of print)
    Meriglier E, Rivoisy C, Hessamfar M, Bernard N, Aureau I, Lapoirie J, Contis A, Sacher F, Sacristan B, Lahouati M, Pedeboscq S, Vandenhende MA, Bouchet S, Bonnet F.
     PubMed citation

  49. Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update
    Drug Saf. 2020 (ahead of print)
    Moore N.
     PubMed citation

  50. Chloroquine for COVID-19 Infection
    Drug Saf. 2020 (43-5) 393-394
    Moore N.
     PubMed citation

  51. No arguments for extra risk from ibuprofen in SARS-COV2 infection
    Therapie. 2020 (ahead of print)
    Moore N.
     PubMed citation

  52. Does Ibuprofen Worsen COVID-19?
    Drug Saf. 2020 (43-7) 611-614
    Moore N, Carleton B, Blin P, Bosco-Levy P, Droz C.
     PubMed citation

  53. The determinants of dyspnoea evaluated by the mMRC scale: The French Palomb cohort
    Respir Med Res. 2020 (ahead of print)
    Ouaalaya EH, Falque L, Dupis JM, Sabatini M, Bernady A, Nguyen L, Ozier A, Nocent-Ejnaini C, Le Guillou F, Molimard M, Raherison-Semjen C.
     PubMed citation

  54. Susceptibility to frequent exacerbation in COPD patients: Impact of the exacerbations history, vaccinations and comorbidities?
    Respir Med. 2020 (169) 106018
    Ouaalaya EH, Falque L, Dupis JM, Sabatini M, Bernady A, Nguyen L, Ozier A, Nocent-Ejnaini C, Le Guillou F, Molimard M, Zysman M, Raherison-Semjen C.
     PubMed citation

  55. Use of benzodiazepines non-compliant with guidelines in patients with psychiatric and non-psychiatric chronic disorders
    Gen Hosp Psychiatry. 2020 (65) 21-27
    Panes A, Verdoux H, Fourrier-Réglat A, Berdaï D, Pariente A, Tournier M.
     PubMed citation

  56. DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus
    Drug Saf. 2020 (ahead of print)
    Pariente A, Labat V, Mansiaux Y, Salvo F, Bégaud B, Raschi E, Faillie JL, Létinier L, Bezin J.
     PubMed citation

  57. Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: case reports and disproportionality analyses in Vigibase®
    Br J Clin Pharmacol. 2020 (ahead of print)
    Perino J, Mottal N, Bohbot Y, Servant V, Berroneau A, Poustis P, Fenaux P, Laribi K, Charbonnier A, Bilion E, Calmettes C, Bégaud B, Pigneux A, Milpied N, Miremont-Salamé G, Théophile H, Dimicoli-Salazar S.
     PubMed citation

  58. Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic
    Pharmacoepidemiol Drug Saf. 2020 (ahead of print)
    Pottegård A, Kurz X, Moore N, Christiansen CF, Klungel O.
     PubMed citation

  59. Risk of bradyarrhythmia related to ticagrelor: a systematic review and meta-analysis
    Pharmacol Res. 2020 (ahead of print)
    Pujade I, Perino J, Mathieu C, Arnaud M, Raschi E, Gatti M, Bezin J, Salvo F.
     PubMed citation

  60. [Management of mild asthma in 2019-2020: What about new international therapeutic proposals (GINA 2019)?]
    Rev Mal Respir. 2020 (ahead of print)
    Raherison C, Deschildre A, Garcia G, Girodet PO, Taillé C, Chenivesse C, Devouassoux G, Molimard M, Didier A.
     PubMed citation

  61. Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction
    J Eur Acad Dermatol Venereol. 2020 (ahead of print)
    Raschi E, Salvo F, La Placa M, Poluzzi E, De Ponti F.
     PubMed citation

  62. Impact of Secured Prescription Implementation for Zolpidem on Hypnotics Use in France: A Time-Series Analysis on National Data
    Ann Fam Med. 2020 (18-4) 345-348
    Rousselot N, Pariente A, Mansiaux Y, Victorri-Vigneau C.
     PubMed citation

  63. Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence
    Therapie. 2020 (75-4) 363-370
    Roustit M, Guilhaumou R, Molimard M, Drici MD, Laporte S, Montastruc JL; French Society of Pharmacology and Therapeutics (SFPT).
     PubMed citation

  64. Effectiveness of first-line cetuximab in wild-type RAS metastatic colorectal cancer according to tumour BRAF mutation status from the EREBUS cohort
    Br J Clin Pharmacol. 2020 (ahead of print)
    Rouyer M, Francois E, Sa Cunha A, Monnereau A, Bignon E, Jove J, Lassalle R, Droz-Perroteau C, Moore N, Noize P, Fourrier-Réglat A, Smith D.
     PubMed citation

  65. Medicine misuse: A systematic review and proposed hierarchical terminology
    Br J Clin Pharmacol. 2020 (ahead of print)
    Singier A, Noize P, Berdaï D, Daveluy A, Arnaud M, Molimard M, Bégaud B, Salvo F.
     PubMed citation

  66. Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study
    BMJ Open. 2020 (10-7) e035811
    Suehs CM, Zysman M, Chenivesse C, Burgel PR, Couturaud F, Deslee G, Berger P, Raherison C, Devouassoux G, Brousse C, Roche N, Molimard M, Chinet T, Devillier P, Chanez P, Kessler R, Didier A, Martinat Y, Le Rouzic O, Bourdin A.
     PubMed citation

  67. Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project
    Pharmacoepidemiol Drug Saf. 2020 (ahead of print)
    Thurin NH, Lassalle R, Schuemie M, Pénichon M, Gagne JJ, Rassen JA, Benichou J, Weill A, Blin P, Moore N, Droz-Perroteau C.
     PubMed citation

  68. Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS)
    Pharmacoepidemiol Drug Saf. 2020 (29-8) 890-903
    Thurin NH, Lassalle R, Schuemie M, Pénichon M, Gagne JJ, Rassen JA, Benichou J, Weill A, Blin P, Moore N, Droz-Perroteau C.
     PubMed citation

  69. Death related to nicotine replacement therapy: A case report
    Forensic Sci Int. 2020 (ahead of print)
    Tjoncke JA, Goncalves R, Castaing N, Molimard M, Tovagliaro F, Titier K.
     PubMed citation

  70. Toxicological screening reveals Toxic Epidermal Necrolysis likely carbamazepine-induced rather than idiopathic
    J Allergy Clin Immunol Pract. 2020 (ahead of print)
    Toussaint C, Sanchez-Pena P, Titier K, Castaing N, Molimard M, Milpied B.
     PubMed citation

  71. Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection
    Antiviral Res. 2020 (ahead of print)
    Venisse N, Peytavin G, Bouchet S, Gagnieu MC, Garraffo R, Guilhaumou R, Solas C; ANRS-AC43 Clinical Pharmacology Committee, SFPT Therapeutic Drug Monitoring and Treatment Personalization group.
     PubMed citation

  72. A highly sensitive UHPLC-MS/MS method for urine biological monitoring of occupational exposure to anthracycline antineoplastic drugs and routine application
    J Chromatogr B Analyt Technol Biomed Life Sci. 2020 (ahead of print)
    Villa A, Tremolet K, Martinez B, Da Silva Cacao O, Atgé B, Ducint D, Titier-Debeaupuis K, Verdun-Esquer C, Molimard M, Canal-Raffin M.
     PubMed citation

  73. A Population Pharmacokinetic Modeling Approach to Determine the Efficacy of Intravenous Amikacin in Children with Cystic Fibrosis
    Ther Drug Monit. 2020 (ahead of print)
    Woillard JB, Bouchet S, Fayon M, Marquet P, Monchaud C, Bui S.
     PubMed citation